Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Biotechniques ; 19(5): 836-41, 1995 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-8588925

RESUMO

Applications for a new polymer resin, PolyFlo, are described for both the small-scale and large-scale purification of synthetic oligodeoxyribonucleotides varying in length from 18-41 bases. The unique properties of this innovative resin provide > 95% purified full-length oligodeoxyribonucleotides with greater than 90% yield starting from either crude trityl-on or trityl-off unmodified as well as base (biotin)- or backbone (e.g., phosphorothioate)-modified products. Full biological activity of recovered nucleic acid is retained, and the resin is capable of removing contaminating endotoxins during purification. The resin performance is predictable and reliable. The resin can be regenerated easily and is particularly economic when employed directly in ammonia or with the trityl-off option. PolyFlo meets the requirements of current Good Manufacturing Practices.


Assuntos
Cromatografia Líquida de Alta Pressão/métodos , Oligodesoxirribonucleotídeos/química , Oligodesoxirribonucleotídeos/isolamento & purificação , Hidróxido de Amônia , Sequência de Bases , Biotina , Eletroforese em Gel de Poliacrilamida , Hidróxidos , Dados de Sequência Molecular , Polímeros , Reprodutibilidade dos Testes , Resinas Vegetais
2.
J Parenter Sci Technol ; 43(1): 15-23, 1989.
Artigo em Inglês | MEDLINE | ID: mdl-2926601

RESUMO

The impact of continuous perfusion cell culture technology on production of one and two chain human rtPA, as well as monoclonal IgG and IgM, will be reviewed. Perfusion as compared to batch systems improve the quality of the product in the conditioned media in terms of biological activity and structural integrity. This significantly increases downstream recovery and daily production output of final purified material. These findings are a consequence of the ability of perfusion technology to 1) maintain cells intact at high cell density; 2) effectively reduce serum content to approximate serum free conditions; and 3) minimize residency time of labile product within the 37 degrees C environment of the bioreactor.


Assuntos
Produtos Biológicos/isolamento & purificação , Tecnologia Farmacêutica/métodos , Células Cultivadas , Cromatografia/métodos , Perfusão
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA